Walgreens Boots Alliance 股本 2024

Walgreens Boots Alliance Aktienanalyse

Walgreens Boots Alliance在做什么？

Walgreens Boots Alliance Inc is a global leader in the health and wellness industry. The company's history dates back to 1901 when Charles R. Walgreen began operating a pharmacy in Chicago. Since then, the company has steadily grown and expanded, eventually merging with Alliance Boots in 2014 to become Walgreens Boots Alliance. The business model of Walgreens Boots Alliance focuses on creating a seamless and integrated experience for customers and patients in all areas of healthcare. The company offers a wide range of products and services, including prescription medications, pharmacy and healthcare services, beauty products, vitamins and supplements, photo processing, and more. Walgreens Boots Alliance operates in three main divisions: retail, pharmaceutical wholesale, and pharmaceutical development and manufacturing. In the retail sector, the company operates over 21,000 pharmacies in 11 countries, including the United States, the United Kingdom, Mexico, and China. The pharmacies offer a wide selection of prescription and over-the-counter medications, as well as health and wellness products. Additionally, Walgreens Boots Alliance operates a number of online platforms and mobile applications designed to provide customers with easy access to medication and healthcare services. In the pharmaceutical wholesale division, the company provides services to pharmaceutical companies, hospitals, and retailers. Walgreens Boots Alliance is the largest pharmaceutical wholesaler in the United States and Europe. The company also operates a number of specialized units that focus on the distribution of medications for specific medical needs and therapies. In the pharmaceutical development and manufacturing division, the company is primarily involved in the production and development of generic and specialty medications. This division also includes research and development of new medications targeting the treatment of serious diseases. The products offered by Walgreens Boots Alliance are diverse and cover a wide range of health and wellness needs. The company is particularly known for its wide selection of medications and pharmacy products, including prescription and over-the-counter medications, as well as supplements and vitamins. In the beauty sector, the company offers a wide range of cosmetic products, skincare products, hair care products, and perfumes. Additionally, Walgreens Boots Alliance also offers photo products, such as photo processing and personalized photo books. Walgreens Boots Alliance is also highly committed to promoting healthcare and public health. The company has established partnerships with various nonprofit organizations and universities to support community health programs and improve healthcare. Overall, Walgreens Boots Alliance has become one of the leading companies in the global health industry. With its wide range of products and services and strong market presence, the company aims to provide customers and patients with a comprehensive and integrated experience in all areas of healthcare. Walgreens Boots Alliance ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Walgreens Boots Alliance 按部门划分的营业额

在Walgreens Boots Alliance股票（US9314271084，A12HJF，WBA）的财务报告中，将其营收分为3个细分市场： 1. Pharmaceutical Wholesale, 2. Retail Pharmacy International, 3. Retail Pharmacy (only USA). Walgreens Boots Alliance 股票（WKN: A12HJF，ISIN: US9314271084，Ticker-Symbol: WBA）是对于有意投资于Consumer Staples行业的投资者来说的一个领先投资选择。

17 % Pharmaceutical Wholesale
7 % Retail Pharmacy International
76 % Retail Pharmacy (only USA)

股本的详细信息

Walgreens Boots Alliance的股本分析

Walgreens Boots Alliance的股本代表了公司的所有者权益，是总资产与总负债之间的差额。它反映了在所有债务都得到偿还之后，股东对公司资产的剩余权益。理解Walgreens Boots Alliance的股本对评估其财务健康，稳定性以及对股东的价值至关重要。

年对年比较

评估Walgreens Boots Alliance连续几年的股本，可以提供有关公司的增长，盈利能力以及资本结构的观点。股本的增长表明净资产和财务健康的改善，而股本的减少可能表明债务的增加或运营上的挑战。

对投资的影响

Walgreens Boots Alliance的股本对投资人来说是一个关键的元素，它影响了公司的杠杆，风险档案以及股本回报率（ROE）。较高的股本水平通常预示着较低的风险和增加的财务稳定性，使得公司可能成为有吸引力的投资机会。

解读股本波动

Walgreens Boots Alliance的股本波动可能源于各种因素，包括净利润的变动，分红，以及发行或回购股票。投资人分析这些变化，以评估公司的财务表现，运营效率和战略财务管理。

关于Walgreens Boots Alliance股票的常见问题

Walgreens Boots Alliance今年的股本是多少？

Walgreens Boots Alliance今年的股本为20.02 亿 USD。

Walgreens Boots Alliance的股本与去年相比高了多少？

Walgreens Boots Alliance的股本与去年相比，-20.79下降了。

Walgreens Boots Alliance的投资者高额的股本会产生什么影响？

对于Walgreens Boots Alliance的投资者来说，高额的股本是有利的，因为它是公司财务稳定性的指标，展示了公司应对风险和挑战的能力。

Walgreens Boots Alliance的投资者低资本充足率会有什么影响？

对于Walgreens Boots Alliance的投资者来说，较低的自有资本可能构成风险，因为这会使公司处于较弱的财务地位，并可能影响其应对风险和挑战的能力。

Walgreens Boots Alliance的股本增加对公司有什么影响?

增加Walgreens Boots Alliance的股本可以强化公司的财务状况，提高其未来投资的能力。

Walgreens Boots Alliance的股本减少会如何影响公司？

Walgreens Boots Alliance的股本减少可能会影响公司的财务状况，并导致对债务资金的依赖度增加。

什么因素会影响Walgreens Boots Alliance的股本？

一些可能影响Walgreens Boots Alliance股本的因素包括利润，股息支付，增资和收购。

为什么Walgreens Boots Alliance的股本对投资者如此重要？

Walgreens Boots Alliance的股本对投资者非常重要，因为它是公司财务实力的指标，也可能是该公司有能力履行其财务义务的迹象。

Walgreens Boots Alliance可以采取哪些战略措施来改变自己的股本？

为了改变自身的股本，Walgreens Boots Alliance可以采取包括提高利润，实施增资，减少开支和收购企业等多种措施。对公司来说，彻底检查其财务状况以确定最佳的策略性措施来改变其股本的情况非常重要。

Walgreens Boots Alliance支付多少股息？

在过去的12个月中，Walgreens Boots Alliance支付了1.92 USD 的股息。这相当于大约12.26 %的股息收益率。在未来的12个月内，Walgreens Boots Alliance预计将支付1.95 USD的股息。

Walgreens Boots Alliance的股息收益率有多高？

Walgreens Boots Alliance当前的股息收益率为12.26 %。

Walgreens Boots Alliance什么时候支付股息？

Walgreens Boots Alliance按季度支付股息。这些股息将在, , , 月份分发。

Walgreens Boots Alliance的股息有多安全？

Walgreens Boots Alliance 在过去53年里每年都支付了股息。

Walgreens Boots Alliance的股息有多高？

预计未来12个月的股息将达到1.95 USD。这相当于12.43 %的股息收益率。

Walgreens Boots Alliance位于哪个行业？

Walgreens Boots Alliance 被分配到“非周期性消费”板块。

Wann musste ich die Aktien von Walgreens Boots Alliance kaufen, um die vorherige Dividende zu erhalten?

要获得Walgreens Boots Alliance在支付的0.25 USD的最后一笔股息，你必须在的除息日之前持有该股票于你的账户中。

Walgreens Boots Alliance最后一次支付股息是什么时候？

上一次股息发放日期为。

Walgreens Boots Alliance在2023年的股息是多少？

在2023年，Walgreens Boots Alliance 分配了1.915 USD作为股息。

Walgreens Boots Alliance 的股息是以哪种货币支付的？

Walgreens Boots Alliance的股息将以USD的形式分配。